Skip to main content

Table 1 Antimicrobial susceptibility profile of S. aureus

From: Characterization of Staphylococcus aureus isolated from patients with burns in a regional burn center, Southeastern China

Antimicrobial S.aureus in SSTI (n = 75) S.aureus in non-SSTI (n = 50)
R(%) I(%) S(%) R(%) I(%) S(%)
Penicillin G 93.3 0.0 6.7 84.0 0.0 16.0
Cefoxitin Screen 90.7 0.0 9.3 62.0 0.0 38.0
Oxacillin 88.0 0.0 12.0 60.0 0.0 40.0
Gentamicin 60.0 2.7 37.3 38.0 2.0 60.0
Ciprofloxin 62.7 2.7 34.6 64.0 2.0 34.0
Levofloxacin 42.7 1.3 56.0 52.0 4.0 44.0
Moxifloxacin 25.3 4.0 70.7 34.0 4.0 62.0
Clindamycin 78.7 2.7 18.6 54.0 2.0 44.0
Erythromycin 90.7 2.7 6.6 50.0 4.0 46.0
Tetracycline 72.0 1.3 26.7 50.0 2.0 48.0
Rifampicin 49.3 2.7 48.0 30.0 2.0 68.0
Quinupristin/Dalfopristin 0.0 0.0 100.0 0.0 0.0 100.0
Trimethoprim/Sulfamethoxazole 18.7 0.0 81.3 16.0 0.0 84.0
Tigecycline 1.3 0.0 98.7 2.0 0.0 98.0
Nitrofurantoin 0.0 0.0 100.0 0.0 0.0 100.0
Linezolid 0.0 0.0 100.0 0.0 0.0 100.0
Vancomycin 0.0 0.0 100.0 0.0 0.0 100.0
  1. SSTI, skin and soft tissue infection